Evidence map›Paper›PMID 32983160›Full record

Trial reportFrontiers in immunology2020

Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock.

Rebecca Halbgebauer, Ebru Karasu, Christian K Braun, Annette Palmer, Sonja Braumüller, Anke Schultze, Fabian Schäfer, Sarah Bückle, Alica Eigner, Ulrich Wachter and 13 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 4 countries.

Rebecca HalbgebauerInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Ebru KarasuInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Christian K BraunInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Annette PalmerInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Sonja BraumüllerInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Anke SchultzeInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Fabian SchäferInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Sarah BückleInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Alica EignerInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Ulrich WachterInstitute for Anesthesiological Pathophysiology and Process Development, University of Ulm, Ulm, Germany.
Peter RadermacherInstitute for Anesthesiological Pathophysiology and Process Development, University of Ulm, Ulm, Germany.
Ranillo R G ResuelloSimian Conservation Breeding and Research Center, Makati, Philippines.
Joel V TuplanoSimian Conservation Breeding and Research Center, Makati, Philippines.
Kristina Nilsson EkdahlDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Bo NilssonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Milena ArmackiDepartment of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Alexander KlegerDepartment of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Thomas SeufferleinDepartment of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Miriam KalbitzDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, Center of Surgery, University Hospital Ulm, Ulm, Germany.
Florian GebhardDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, Center of Surgery, University Hospital Ulm, Ulm, Germany.
John D LambrisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Martijn van GriensvenMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Cell Biology-Inspired Tissue Engineering, Maastricht University, Maastricht, Netherlands.
Markus Huber-LangInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
University Hospital Ulm · DEUniversität Ulm · DELinnaeus University · SEMaastricht University · NLUniversity of Pennsylvania · USUppsala University · SE

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
NIAID NIH HHS P01 AI068730
6 · The paper itself

Abstract

Trauma represents a major socioeconomic burden worldwide. After a severe injury, hemorrhagic shock (HS) as a frequent concomitant aspect is a central driver of systemic inflammation and organ damage. The kidney is often strongly affected by traumatic-HS, and acute kidney injury (AKI) poses the patient at great risk for adverse outcome. Recently, thirty-eight-negative kinase 1 (TNK1) was proposed to play a detrimental role in organ damage after trauma/HS. Therefore, we aimed to assess the role of TNK1 in HS-induced kidney injury in a murine and a

Indexed as

Acute Kidney InjuryAnimalsCells, CulturedComplement C3Fetal ProteinsHealthy VolunteersHumansInflammation MediatorsInterleukin-6KidneyMaleMiceMice, Inbred C57BLModels, AnimalPrimatesProtein-Tyrosine KinasesComplement C3Fetal ProteinsInflammation MediatorsInterleukin-6Protein-Tyrosine KinasesTNK1 protein, humanAKIblood losscomplementIL-6inflammationinjuryTNK1trauma

Identifiers

PMID32983160
PMCPMC7479097
OpenAlexW3080172704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.